Nanotube-mediated efficiency of cisplatin anticancer therapy
- 1 April 2014
- journal article
- Published by Elsevier BV in Carbon
- Vol. 70, 46-58
- https://doi.org/10.1016/j.carbon.2013.12.060
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Targeting and delivery of platinum-based anticancer drugsChemical Society Reviews, 2012
- Targeting carbon nanotubes against cancerChemical Communications, 2012
- The status of platinum anticancer drugs in the clinic and in clinical trialsDalton Transactions, 2010
- Advances in Platinum ChemotherapeuticsChemistry – A European Journal, 2010
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomasJournal of Dermatological Science, 2007
- Poly(γ,l-glutamic acid)–cisplatin conjugate effectively inhibits human breast tumor xenografted in nude miceBiomaterials, 2006
- The development of platinum compounds and their possible combinationCritical Reviews in Oncology/Hematology, 2006
- Platinum Complexes as Anticancer AgentsRecent Patents on Anti-Cancer Drug Discovery, 2006
- Cisplatin-induced renal toxicity and toxicity-modulating strategies: a reviewCancer Chemotherapy and Pharmacology, 1994